Evotec SE (OTCMKTS:EVTCY - Get Free Report) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $4.25 and traded as low as $4.00. Evotec shares last traded at $4.04, with a volume of 48,150 shares changing hands.
Evotec Stock Up 1.7 %
The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50. The company has a market capitalization of $1.36 billion, a price-to-earnings ratio of 10.02 and a beta of 0.98. The firm has a 50-day moving average price of $4.62 and a two-hundred day moving average price of $4.24.
Evotec Company Profile
(
Get Free Report)
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
Before you consider Evotec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evotec wasn't on the list.
While Evotec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
